Literature DB >> 30955965

Open surgery and endovascular repair for mycotic aortic aneurysms: Benefits beyond survival.

Ming-Yuan Liu1, Yang Jiao1, Yang Yang1, Qingle Li1, Xuemin Zhang1, Wei Li2, Xiaoming Zhang3.   

Abstract

OBJECTIVE: Endovascular techniques have been increasingly used to treat mycotic aortic aneurysms. However, apart from survival, the potential benefits of open surgery and endovascular repair for mycotic aortic aneurysms are poorly understood. The aim of this study was to evaluate the short- and mid-term outcomes after open surgery versus endovascular repair for mycotic aortic aneurysms.
METHODS: All patients treated for mycotic aortic aneurysms at Peking University People's Hospital between 2001 and 2017 were identified. Survival was analyzed using Kaplan-Meier analysis and log-rank tests. The reoperation rate was analyzed using a competing-risk analysis.
RESULTS: Forty-three patients were identified. The mean follow-up time was 41 months (median, 29; range, 1-135 months). The 30-day mortality in the open surgery group was 8.7% (2/23) versus 5% (1/20) in the endovascular repair group (P = .999). The overall survival for open surgery and endovascular repair was 78% versus 75%, respectively, at 1 year, and 69% versus 41% (P = .210), respectively, at 5 years. But during the follow-up, the open surgery group demonstrated multiple benefits, including a shorter length of hospital stay (26.80 ± 14.1 days vs 42.73 ± 21.22 days, P = .026), fewer readmissions (mean 0.61 vs 1.30, P = .037), and lower infection-related reoperations (P = .018) than endovascular repair at 3 years. Subgroup analysis revealed better survival for open surgery in patients with a periaortic mass less than 20 mm (P = .03).
CONCLUSIONS: There were no significant differences between endovascular repair and open surgery in survival. However, in the mid-term, the potential benefits of open surgery are favorable compared with endovascular repair, including lower infection-related reoperation rates and reduced medical burden.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  endovascular repair (Endo); infected aortic aneurysm; mycotic aortic aneurysms (MAAs); open surgery; reinfection

Year:  2019        PMID: 30955965     DOI: 10.1016/j.jtcvs.2019.02.090

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  2 in total

1.  Hybrid surgery for a severe infectious innominate artery pseudoaneurysm compressing the main trachea.

Authors:  Li-Shan Lian; Zhe Zhang; Hai Feng; Xue-Ming Chen
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

Review 2.  Therapeutic effectiveness of tuberculous aneurysm and risk factors for mortality: a systematic review.

Authors:  Shengwu Yi; Lingjie Sheng; Wei Li
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.